Bank7 Corp. BSVN
55.85
0.56
1.01%
as of 25 Sep
- Market cap
- $526.7M
- P/E
- 12.6×
Follow BSVN
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
10.02 | 8.97 | 8.43 | 11.05 |
P/S ratio |
3.18 | 2.82 | 2.69 | 3.37 | |
P/FCF ratio |
9.66 | 9.35 | 7.99 | 9.47 | |
P/Operating CF |
26.30 | 42.72 | 22.73 | 62.18 | |
P/B ratio |
1.81 | 1.54 | 1.46 | 1.75 | |
Price to Tangible BV |
1.90 | 1.62 | 1.53 | 1.83 | |
EV/Sales |
1.33 | 0.98 | 0.92 | 1.78 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
3.64 | 2.90 | 2.51 | 4.93 | |
EV/FCF |
4.03 | 3.24 | 2.75 | 5.00 | |
Quick Ratio |
0.16 | 0.15 | 0.15 | 0.13 | |
Current Ratio |
1.09 | 1.09 | 1.10 | 1.11 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.08 | 0.07 | 0.08 | 0.07 | |
Operating CF/Net income |
1.53 | 0.84 | 1.39 | 0.90 | |
Capex/Depreciation |
(0.64) | (3.25) | (7.50) | 9.58 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
30.76% | 28.70% | 28.92% | 37.25% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
2.34% | 2.33% | 1.84% | 1.86% | |
Graham Net Nets |
0.35 | 0.42 | 0.45 | 0.38 | |
Graham Number |
51.56 | 52.28 | 53.98 | 52.81 | |
Earnings Yield |
9.98% | 11.15% | 11.86% | 9.05% | |
Free Cash Flow Yield |
10.35% | 10.70% | 12.52% | 10.56% | |
Revenue per Share |
3.80 | 3.67 | 3.77 | 3.35 | |
Operating CF per Share |
1.76 | 0.96 | 1.75 | 0.79 | |
Capex per Share |
(0.02) | (0.11) | (0.26) | 0.33 | |
Free Cash Flow per Share |
1.74 | 0.84 | 1.49 | 1.12 | |
Cash per Share |
27.16 | 27.01 | 26.39 | 23.33 | |
Shareholders Equity per Share |
25.58 | 26.58 | 27.38 | 27.98 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
25.58 | 26.58 | 27.38 | 27.98 | |
Free Cash Flow |
16.42 | 7.98 | 14.18 | 10.63 | |
Working Capital |
152.66 | 161.97 | 170.48 | 175.71 | |
Capital Expenditures |
(0.21) | (1.08) | (2.47) | 3.13 | |
Net Current Asset Value |
152.66 | 161.97 | 170.48 | 175.71 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.03 | 0.07 | (0.10) | |
Net Profit Margin |
30.18% | 31.12% | 33.58% | 26.14% | |
Price to Operating Income |
7.63 | 6.82 | 6.43 | 8.44 | |
| Other line items | |||||
Average Payables |
1,580.52 | 1,608.15 | 1,611.34 | 1,615.97 | |
Average Assets |
1,815.94 | 1,851.72 | 1,865.28 | 1,875.34 | |
Average Common Equity |
222.95 | 232.10 | 240.74 | 249.08 |
Columns are period end dates